mopidamol has been researched along with Carcinoma, Non-Small Cell Lung in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blaha, H; Dierkesmann, R; Feuerer, W; Gatzemaier, U; Geser, C; Lemme, J; Mall, W; Ritscher, R; Schneider, B; Vallee, D | 1 |
Livingston, RB | 1 |
1 trial(s) available for mopidamol and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
[Adjuvant therapy of non-small cell bronchial cancer with mopidamol].
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Combined Modality Therapy; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mopidamol; Prospective Studies; Pyrimidines; Random Allocation | 1989 |
2 other study(ies) available for mopidamol and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
Mopidamol in non-small cell lung cancer: anti-oncogene or accident?
Topics: Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Mopidamol; Oncogenes; Pyrimidines | 1988 |
Mopidamol.
Topics: Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Mopidamol; Pyrimidines | 1988 |